^Li Y, Shen G, Yu C, Li G, Shen J, Gong J, Xu Y (December 2014). "Angiotensin II induces mitochondrial oxidative stress and mtDNA damage in osteoblasts by inhibiting SIRT1–FoxO3a–MnSOD pathway". Biochemical and Biophysical Research Communications. 455 (1–2): 113–8.
doi:
10.1016/j.bbrc.2014.10.123.
PMID25450701.
^Zainabadi K (May 2019). "Drugs targeting SIRT1, a new generation of therapeutics for osteoporosis and other bone related disorders?". Pharmacological Research. 143: 97–105.
doi:
10.1016/j.phrs.2019.03.007.
PMID30862606.
S2CID76663834.
^Lin X, Liu C, Wang T, Wang H, Shao Z (2019). "Sirt1 in the Regulation of Interferon Gamma in Severe Aplastic Anemia". Acta Haematologica. 142 (3): 142–148.
doi:
10.1159/000497404.
PMID31141802.
S2CID169038775.
^Li Y, Shen G, Yu C, Li G, Shen J, Gong J, Xu Y (December 2014). "Angiotensin II induces mitochondrial oxidative stress and mtDNA damage in osteoblasts by inhibiting SIRT1–FoxO3a–MnSOD pathway". Biochemical and Biophysical Research Communications. 455 (1–2): 113–8.
doi:
10.1016/j.bbrc.2014.10.123.
PMID25450701.
^Zainabadi K (May 2019). "Drugs targeting SIRT1, a new generation of therapeutics for osteoporosis and other bone related disorders?". Pharmacological Research. 143: 97–105.
doi:
10.1016/j.phrs.2019.03.007.
PMID30862606.
S2CID76663834.
^Lin X, Liu C, Wang T, Wang H, Shao Z (2019). "Sirt1 in the Regulation of Interferon Gamma in Severe Aplastic Anemia". Acta Haematologica. 142 (3): 142–148.
doi:
10.1159/000497404.
PMID31141802.
S2CID169038775.